Shareholder Rights Advocates at Levi & Korsinsky Investigate Viking Therapeutics, Inc. (VKTX) Regarding Possible Securities Fraud Violations
Portfolio Pulse from
Levi & Korsinsky is investigating Viking Therapeutics, Inc. (VKTX) for potential securities fraud violations. This follows a 9% stock price increase after positive trial data for their anti-obesity drug VK2735 was released.
November 12, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Viking Therapeutics is under investigation for potential securities fraud following a 9% stock price increase after releasing positive trial data for their drug VK2735.
The investigation by Levi & Korsinsky into possible securities fraud could negatively impact investor confidence in Viking Therapeutics, potentially leading to a short-term decline in stock price despite the recent positive trial data.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100